Latest papers

Using inverse probability-weighted estimators in comparative effectiveness analyses with observational databases.

Sleep duration and insulin resistance in obese children: when variables are sleeping too close together.

Population-based breast cancer statistics in Korea during 1993-2002: incidence, mortality, and survival.

Cancer survival in Korea 1993-2002: a population-based study.

Moderators and mediators of treatment outcome for youth with ADHD: understanding for whom and how interventions work.

The autism epidemic: fact or artifact?

[Medical demography: how to fight against the medical deserts?]

Comment on "Developing policy in the face of scientific uncertainty: interpreting 0.3 microT or 0.4 microT cutpoints from EMF epidemiologic studies" by Kheifets et al. in Risk Analysis, 25(4), 927-935.

Educational differences in the dynamics of disability incidence, recovery and mortality: Findings from the MRC Cognitive Function and Ageing Study (MRC CFAS).

Assessing dose-response relationships by cumulative exposures in epidemiological studies.

Reporting birth defects surveillance data 1968-2003.

Epidemiological transitions and the changing face of medical geology.

Determinants of smoking and cessation in older women.

Effect of general population mortality on the north-south mortality gradient in patients on replacement therapy in Europe.

Regional mortality differences in end-stage renal disease: how far can observational studies take us?

Curbing industry sponsor's incentive to design post-approval trials that are suboptimal for informing prescribers but more likely than optimal designs to yield favorable results.

Role of leptin in reverse epidemiology in chronic kidney disease.

Reverse epidemiology beyond dialysis patients: chronic heart failure, geriatrics, rheumatoid arthritis, COPD, and AIDS.

Body mass index and peritoneal dialysis: "exceptions to the exception" in reverse epidemiology?

Reverse epidemiology in patients with chronic kidney disease who are not yet on dialysis.